Citigroup Issues Pessimistic Forecast for Bruker (NASDAQ:BRKR) Stock Price

Bruker (NASDAQ:BRKR – Free Report) had its price target decreased by Citigroup from $75.00 to $50.00 in a research note published on Monday morning,Benzinga reports. Citigroup currently has a buy rating on the medical research company’s stock. Several other research analysts also recently issued reports on BRKR. Stifel Nicolaus lowered their price objective on shares […]